Mesoblast (ASX: MSB) – Mesoblast 2025 Annual Financial Results
Mesoblast Limited has delivered a significant commercial milestone with Ryoncil, the first-in-class FDA-approved mesenchymal stem cell therapy,...
Mesoblast Limited has delivered a significant commercial milestone with Ryoncil, the first-in-class FDA-approved mesenchymal stem cell therapy,...
Qantas Airways has reported full-year results for the 12 months to 30 June 2026 that reveal a company navigating challenging operating conditions....
Smartgroup has reported solid first-half results that demonstrate the salary packaging specialist is translating market tailwinds into both revenue...
Smartgroup Corporation delivered record results in the first half of 2026, reporting revenue of $179.5m, up 13% from the prior year period, while...
Smartgroup Corporation has reported half-year results to 30 June 2026 demonstrating solid operational growth, with revenue of approximately $20.4...
Atlas Arteria Limited has released its Investor Reference Pack for the half year ended 30 June 2026, marking the company's continued efforts to keep...
Atlas Arteria has released its half year results presentation for the period ending 30 June 2026, offering investors an update on the performance of...
Mesoblast Limited has released its preliminary final report for the fiscal year ended June 30, 2026, with the company's American Depositary Shares...
Eagers Automotive has delivered record revenue growth for the first half of 2026, with turnover reaching $8.1 billion, representing 24% expansion...
Eagers Automotive delivered record first half results for 2026, posting revenue of $8.1 billion, up 24.0 percent on the prior corresponding period,...
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000